covid-19 outbreak

The 2020 SDi Global Assessment has been updated for the first time in the publication history of the report in response to the COVID-19 Pandemic. The 2020 SDi Global Assessment Report contains insights into the impact of the COVID-19 pandemic on the global instrumentation industry. With this completely updated report and a new add-on item, the Global Quarterly Datastream, your company can leverage […]

second wave

As COVID-19 has spread from its origins to almost every corner of the world over the past six months, it has engendered major changes around the globe. The virus has caused a global slowdown due to lockdowns, supply chain disruptions, and reduced production levels, while also stimulating a vaccine race among pharmaceuticals and biotech companies. […]

Global Business COVID-19

The world has been justly preoccupied with the spread of COVID-19 throughout the world and its effects on human health. From a science standpoint, the life science and analytical instrumentation industry has responded to help combat the disease, by supporting research into better diagnosis, treatment, and prevention of the disease. From a business perspective, there […]

infrared spectroscopy

With the ongoing COVID-19 pandemic, we have seen many industries upended by drastic changes in demand. The effects of this could easily be seen in any grocery store at the initial onset of various lockdown orders. While bundles of toilet paper and canned foods were disappearing from store shelves, another hot commodity was hand sanitizer. […]

terahertz spectroscopy

While standard viral tests involving PCR are the primary way to diagnose an active COVID-19 infection, researchers are naturally pursuing alternatives that may provide other advantages. Currently, there is a focus on developing antibody tests, for instance, which could also determine whether a patient had previously been infected, helping epidemiologists better understand the spread of […]

The latest report from SDi examines the bioprocessing market which they project will grow at a compound annual growth rate (CAGR) of 9.0% during the next five years. The global demand for biopharmaceuticals is expanding at a rapid pace, as they are more extensively accepted for the clinical treatment of a wide range of ailments. […]